Susan G. Komen: Tarah Ballinger presents results from the EAZ171 trial at ASCO24

Tarah Ballinger, Assistant Professor of Clinical Medicine at Indiana University School of Medicine, shared a post by Susan G. Komen, on X/Twitter, adding:

”Thank you Susan G. Komen for your support!!”

Quoting Susan G. Komen’s post:

”Komen grantee Tarah Ballinger presents results from the EAZ171 trial at ASCO24. The results showed that docetaxel resulted in less grade 2 neuropathy, a painful side effect from some chemotherapy drugs, than paclitaxel for Black women.”

Source: Tarah Ballinger/X and Susan G. Komen/X